Gilead Sciences (GILD) Misses Q1 EPS by 19c, Reiterates FY Guidance
Tweet
Share
E-mail
Get Alerts GILD Hot Sheet
Price: $146.64 -2.89%
EPS Growth %: -14.2%
Financial Fact:
Net loss attributable to noncontrolling interest: -5M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -14.2%
Financial Fact:
Net loss attributable to noncontrolling interest: -5M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Gilead Sciences (NASDAQ: GILD) reported Q1 EPS of $1.48, $0.19 worse than the analyst estimate of $1.67. Revenue for the quarter came in at $5.1 billion versus the consensus estimate of $5.4 billion.
- Gilead reiterates its full year 2018 guidance
For earnings history and earnings-related data on Gilead Sciences (GILD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- Mission Produce (AVO) Misses Q3 EPS by 2c; offers outlook
- Braze, Inc. (BRZE) Tops Q2 EPS by 4c; offers guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
